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Abstract
End-stage renal disease (ESRD) is currently the ninth leading cause of death in the
United States, and of the 661,00 Americans diagnosed with ESRD, approximately 468,800 were
on hemodialysis in 2016. Hemodialysis refers to a technique where a machine combined with a
membrane, often referred to as an artificial kidney, is used to clean blood by removing any waste
such as urea, potassium, and other smaller waste products while preserving the concentrations
and integrity of cells and proteins in the blood. It has been shown in artificial blood studies that
cellulose nanomaterials, like TEMPO/Oxidized cellulose nanoparticles (TOCNs), can be
integrated into membranes that subsequently display desirable membrane and membrane
transport properties such as increased flux, urea clearance and fouling resistance. The focus of
this study was on the application of three variants of these hollow fiber mixed-matrix membranes
that were derived from two types (partially/fully oxidized) of TOCNs. Hemodialysis was
performed using hematocrit adjusted bovine blood to analyze a number of transport properties of
each membrane including protein rejection, blood cell rejection, ionic permeability, and urea
clearance. The 50/50 mixed-matrix membrane showed promising results with its high ionic
permeability to divalent cations and improved urea clearance and theoretical treatment time all
while retaining a comparable concentration of erythrocytes, leukocytes, thrombocytes, and blood
proteins. Form I and Form II both rejected blood cells and proteins similar to 50/50, however,
they both had a reduced permeability to divalent cations while also showing little to no
improvement in urea clearance or treatment time when compared to the control. For these
reasons, the 50/50 membrane was distinguished as the most viable membrane to base future
blood hemolysis and membrane characterization studies around due to its exceptional urea
clearance, reduction of theoretical treatment time, and desirable ionic permeability properties.
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1. Introduction
According to the Center for Disease Control and Prevention, it is estimated that more
than 1 in 7 US adults currently have chronic kidney disease (CKD)[1]. CKD occurs when an
individual’s kidneys become damaged and lose their ability to adequately filter their blood. If left
untreated, CKD has the possibility to progress to further health complications such as kidney
failure, also known as end-stage renal disease (ESRD), which is currently the ninth leading cause
of death in the United States [1]. The two main treatments for ESRD are dialysis or a kidney
transplant, however, according to the National Institute of Diabetes and Digestive and Kidney
Diseases, of the approximately 661,000 Americans diagnosed with ESRD, 468,000 were on
dialysis while only 193,000 were living with transplants in 2016 [2]. Kidney transplants have
been shown to provide an improved quality of life and reduced risk of mortality over dialysis,
however, the most recent available statistics from the U.S. Department of Health and Human
Services shows that there were 92,194 Americans on the waitlist for a kidney transplant at the
end of 2018, and 40% of individuals that were on the waitlist in 2015 were still on the waitlist in
2018 [3][4].
While individuals suffering from ESRD might wait years for a kidney transplant, there is
a clear need to make improvements upon the current dialysis treatments that are relatively widely
available when compared to eligible kidney donors that match. One of the main types of dialysis
that patients with ESRD will undergo is hemodialysis. Hemodialysis refers to a technique where
a machine combined with a membrane is used to clean blood by removing any waste such as
urea, potassium, and other smaller waste products. A dialysate solution is used as a washing fluid
to create an osmotic and chemical gradient for the waste in the blood to make an exchange across
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the semipermeable membrane by simple diffusion. By changing the ionic concentrations and
composition of the dialysate, a hemodialysis machine can be finely tuned to select for which ions
of the blood should be removed or added. The membrane is often referred to as a dialyzer or
artificial kidney since it is the component of the hemodialysis machine which filters and has
direct contact with the patient’s blood. The dialyzers are hollow fiber membranes that allow
blood to pass through the center of the straw-like cylinders while the dialysate solution is
pumped countercurrent to the direction of the blood flow within the hollow fiber membranes.
Figure 1 below provides a representation of a simplified hemodialysis machine.

Figure 1: A hemodialysis hollow fiber module. [5]

Roller 5

There are a number of high performance dialyzers that are currently on the market which
are made from synthetic materials such as polysulfone (PSf) or cellulose triacetate (CTA). These
materials are favored for use in hemodialysis due to their excellent biocompatibility and ability
to effectively clear target solutes with pore sizes larger than most conventional hemodialysis
membranes [6]. Since cellulose is the most abundant natural polymer on Earth, it is a very
appealing material to work with because it is relatively inexpensive and easy to handle. It is also
well documented that cellulose membranes can be modified to improve their performance during
hemodialysis thus decreasing the mortality rate when compared to other unmodified membranes
[7]. Through the use of cellulose nanomaterials (CNM), these existing CTA membranes can be
further modified to improve a multitude of membrane properties such as membrane strength and
hydrophilicity, and transport properties which could consequently improve membrane separation
[8]. Preliminary research on CNM modifications on cellulose membranes, specifically the Form
I, Form II, and 50/50 hollow fiber Oxone mediated TEMPO-oxidized nano cellulose mixedmatrix membranes produced by Kristyn Robling in her 2019 thesis, have shown promising
membrane properties such as increases in flux, mass transfer area coefficient, urea clearance, and
antifouling properties [9]. TEMPO-cellulose Form I is partially oxidized while TEMPOcellulose Form II is fully oxidized. The chemical structure and recently developed production
method of these two derivatives can be seen in Figure 2 below.
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Figure 2: The production method from micron cellulose in microwave irradiation conditions
of Form I and Form II, and the both derivatives chemical structures. [10]

In collaboration with the University of Arkansas for Medical Sciences, and continuing
the work done by Kristyn Robling, it is the goal of this research to further characterize the Oxone
mediated TEMPO-oxidized nano cellulose mixed-matrix membranes through a series of in vitro
hemodialysis studies using hematocrit adjusted bovine blood. It is hypothesized that the
derivatives Form I will show an increases in urea clearance and ion permeability, and will
display comparable biocompatible properties to the control, CTA membranes.

2. Materials and Method
2.1 Materials
Assembled modules each containing 20 fibers of a designated type, CTA, Form I, Form
II, 50/50, were previously assembled following the procedures outlined in Robling’s 2019 thesis.
These hollow fiber membranes were created using CTA from Millipore Sigma, Nmethylpyrrolidone (NMP), and deionized water along with pure TEMPO/Oxone-oxidized
cellulose nanocrystals (TOCNs) and Form I and Form II samples that were prepared by Dr. Peter
A. Crooks from the University of Arkansas for Medical Sciences. The membranes were
developed according to the proportions laid out in Table 1 below.
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Table 1:Composition by weight percentage that the three modified membranes were composed
according to. [9]

Hematocrit adjusted bovine blood from Lampire Biological Labs was used as a model for
human blood throughout the experiments. A fluid pump, dialysate (PBS) solution, warm water
bath, pressure-rated heparinized dialysis tubing, and beakers to receive the feed out and dialysate
out were required to begin experimental setup. A 70% ethanol solution would be frequently
required to sterilize the station, and proper personal protective equipment was necessary as these
experiments would be with animal blood.

2.2 Hemodialysis
To prepare for hemodialysis experiments, the modules were activated through a
membrane conditioning step. This step is crucial because it essentially primes the membranes for
the remainder of the experiment by allowing them to adjust to the aqueous pressurized
environment. The flux of these membranes will vary slightly over time shortly after being
exposed to a solution. To condition the modules, they were loaded into the apparatus in such a
way that the eventual dialysate would run countercurrent to the feed bovine blood that would
travel through the 20 hollow fibers, however, the membranes were initially activated using 25 °C
deionized water with a consistent transmembrane pressure of 3 psig for one hour. The deionized
water was passed through the dialysate and feed space both inside and outside of the hollow
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fibers. Once the membranes reached a more stable state where the pure water flux was changing
less the 5% per minute, then the blood studies would be initiated. The feed was run at a flow rate
of 300 mL/min and the dialysate was run at a flow rate of 500 mL/min.
While the membranes were being conditioned, the feed bovine blood was warmed in a
bath to a temperature of 37 °C. When stabilization was reached, the necessary connections were
switched to facilitate hemodialysis, which involved removing the deionized water feed
connections and connecting warmed bovine blood to the feed in. The blood was allowed to clean
run for a few minutes to clear out the residual water that was left in the system. Modules were
then run in parallel in the interest of time for thirty minutes making sure to collect the used
dialysate and feed blood. Samples were then taken to be analyzed later. Upon completion of the
first two modules, these modules were switched out to run the remaining two.
When all samples were collected, the hemodialysis was shut down and the module was
disconnected. A 70% ethanol/water mixture was run through the apparatus without the modules
attached to disinfect it. All materials were properly sanitized and disposed of in the proper bins.

2.3 Sample Testing
The samples collected during hemodialysis were tested using a 96-well plate reading UVvis spectrophotometer with a colorimetric assay for urea concentration. For protein analysis,
samples were sent off to the Central Analytical Laboratory in Poultry Science Center at
University of Arkansas where serum protein quantity was analyzed by free nitrogen adsorption
method. Blood analysis was performed in poultry science on the multi-animal blood analyzer.
Lastly, salt concentration was analyzed using inductive coupled plasma ISP.
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3. Results
3.1 Protein Analysis
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Figure 3: Protein concentrations measured for the dialysate solutions that are used for the
corresponding membrane type.

Serum protein quantity that was analyzed by free nitrogen adsorption method showed that
all membranes performed essentially the same with the biggest difference of 0.02% in dialysate
protein concentration being between the 50/50 and control dialysates. This suggests that all three
TOCN membranes reject blood proteins at a similar rate as the CTA control.
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3.2 Ionic Transport Characterization
A
B

B

C

D

Figure 4: Varying ion concentrations measured for the dialysate solutions that are used for the
corresponding membrane type. Ions tested included: (A) Na+, (B) K+, (C) Mg2+, (D) Ca2+.

All modules performed similarly for allowing the monovalent cations, sodium and
potassium, to pass through the membranes. However, when it came to the divalent cations,
magnesium and calcium, the 50/50 membrane seemed to be much more permeable than the
control, Form I, or Form II. A higher ion permeability would suggest that hemodialysis could be
more easily controlled by close monitoring of patient blood ion levels and necessary adjustment
of dialysate solution composition.
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3.3 Blood Transport Characterization
Table 2: The blood transport characteristics of cellulose dialysis membranes.
Platelet Rejection White Blood Cells Red Blood Cells
%
K/uL
M/uL
Initial Blood
N/A
10.36
7.33
Form I
0.98
0.02
0
50/50
0.98
0.02
0
Form II
0.98
0.02
0
Control
0.98
0.02
0
Sample

Hemoglobin Concentration
g/dL
10.1
0
0
0
0

Platelets
K/mL
447
7
11
7
9

All three mixed-matrix membraned showed the ability to reject erythrocytes, leukocytes,
and thrombocytes in the blood as efficiently as the control. Platelet counts in the permeates were
comparable to the control. These results suggest that all tested mixed-matrix membranes have
pore sizes that are small enough to prevent important blood components, which are retained
within the kidneys in normal renal filtration, from leaking into the permeate and causing the
blood to become anemic.

3.4 Urea Transport Characterization
Table 3: The urea transport characteristics of cellulose dialysis membranes.
Membrane
Sample

KoA

Experimental
Clearance
(mL/min)

Theoretical Clearance for
1 m2
membrane (mL/min)

Theoretical time to reach
kt/V of 1.2 (minutes)

Form I
50/50
Form II
CTA

685
1261
888
842

7.7
11.9
9.2
10.1

237
275
255
251

213
183
198
200

The KoA is the mass transfer area coefficient. The mass transfer area coefficient is a
number that can provide a theoretical clearance value when there is infinite blood and dialysate
flow rates. A was membrane surface area for each module. Fick’s law (Equation 1 below) was
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used to calculate the mass transfer area coefficients for each module tested. The solute transport
rate, N, was calculated using Equation 2. ∆𝑪𝑴 was the log mean concentration difference and
was calculated using Equation 3 below. The experimental clearance, KExperimental, was calculated
using Equation 4 below. The mass transfer coefficient and experimental urea clearance values for
each module tested are in Table 3 above.
Equation 1: 𝑵 = 𝑲𝒐𝑨 𝑨(∆𝑪𝑴 )
Equation 2: 𝑵 = 𝑸𝒇 (𝑪𝒇𝒊 − 𝑪𝒇𝒐 ) = 𝑸𝒅 (𝑪𝒅𝒐 − 𝑪𝒅𝒊 )

Equation 3: ∆𝑪𝑴 =

(𝑪𝒇𝒊 −𝑪𝒅𝒐 )−(𝑪𝒇𝒐 −𝑪𝒅𝒊 )
𝑪𝒇𝒊−𝑪𝒅𝒐

𝒍𝒏(

𝑪𝒇𝒐 −𝑪𝒅𝒊

Equation 4: 𝑲 = (𝑪

)

𝑵

𝒇𝒐 −𝑪𝒅𝒊 )

The KExperimental, log mean concentration difference, mass balance, and Fick’s law were
all used to solve for the theoretical clearance for a membrane with a surface area of 1 m2. This
solved equation (Equation 5) can be found below where Qf is equal to the flow of the feed blood
and Z is the blood flow rate divided by the dialysate flow rate. R is equal to the mass transfer
coefficient multiplied by the theoretical membrane area, which in this case is 1 m2, divided by
the flow rate of the dialysate.
𝟏−𝐞𝐱𝐩 (𝑹(𝟏−𝒁))

Equation 5: 𝑲 = 𝑸𝒇 𝒁−𝐞𝐱𝐩 (𝑹(𝟏−𝒁))
The theoretical clearance of a 1 m2 membrane was then used to calculate the theoretical
treatment time. A model person with a mass of 70 kg and a 60% water weight was used to
calculate the theoretical treatment time for them to reach a Kt/V of 1.2, which corresponds to the
Kt/V target set by the US National Kidney Foundation. Results showed that the 50/50 membrane
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reduced the treatment time by the greatest amount. Form II had a similar treatment time to the
control while Form I had a higher theoretical treatment time than the control.

4. Conclusion
After analysis of each membrane, there were improvements found for the 50/50 module
over the control (CTA) high performance membrane when it came to divalent cation
permeability and urea clearance while also performing similarly to the control with regards to
rejection of major erythrocytes, leukocytes, thrombocytes and blood. All three mixed-matrix
membranes were slightly more permeable to monovalent cations than the control, and all three
proved to reject proteins and cells in the blood at a comparable level as the CTA control
membranes. When determining theoretical treatment times, 50/50 was found to have largest mass
transfer coefficient and the shortest treatment time compared to the control. Although it was
predicted that the Form I module would perform best during hemodialysis, it appears that the
50/50 module had the best performance and is a promising candidate for further hemodialysis
testing of itself and varying derivatives of mixtures of Form I and Form II in the future.

5. Future Work
The next step in experiments with these membranes with regards to hemodialysis should
involve developing new membranes of varying ratios to form a clearer picture of the interaction
of the two CNMs in the membranes. Given that these CNM mixed-matrix membranes displayed
biocompatible properties throughout this research and have previously shown low-fouling
properties, the potential for the eventual development of an implantable artificial kidney device
should be investigated as current technology progresses.

Roller 14

6. Acknowledgements
Special thanks to my thesis advisor, Dr. Jamie Hestekin for his committed guidance and
assistance throughout this thesis project. I would also like to recognize and show my
appreciation to both John Moore and Efecan Pakkaner, University of Arkansas Chemical
Engineering Graduate students, for their enthusiastic assistance and unwavering commitment to
guide me throughout the course of this research.

Roller 15
References
1. “Chronic Kidney Disease Basics.” Center for Disease Control and Prevention, 7 Feb. 2020,
www.cdc.gov/kidneydisease/basics.html#about.
2. “Kidney Disease Statistics for the United States.” National Institute of Diabetes and Digestive
and Kidney Diseases Health Information Center, Dec. 2016, www.niddk.nih.gov/healthinformation/health-statistics/kidney-disease.
3. Tonelli M, Wiebe N, Knoll G, Bello A, Browne S, Jadhav D, Klarenbach S, Gill J.
“Systematic Review: Kidney Transplantation Compared With Dialysis in Clinically
Relevant Outcomes.” American Journal of Transplantation, 2011, pp. 2093–2109.,
https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1600-6143.2011.03686.x.
4. Hart, A., Smith, J. M., Skeans, M. A., Gustafson, S. K., Wilk, A. R., Castro, S., Foutz,
J., Wainright, J. L., Snyder, J. J. Kasiske, B. L. & Israni, A. K. OPTN/SRTR 2018
Annual Data Report: Kidney. Am J Transplant 2019; 20 ( Suppl 1): 20– 130.
doi: 10.1111/ajt.15672
5. “Hemodialysis.” National Institute of Diabetes and Digestive and Kidney Diseases, Jan. 2018,
www.niddk.nih.gov/health-information/kidney-disease/kidney-failure/hemodialysis.
6. “A Clinical Update on Dialyzer Membranes: State-of-the-Art Considerations for Optimal Care
in Hemodialysis.” National Kidney Foundation, 2013,
www.kidney.org/sites/default/files/02-10-6050_FBD_Clinical_bulletin.pdf.
7. Koda, Y, et al. “Switch from Conventional to High-Flux Membrane Reduces the Risk of
Carpal Tunnel Syndrome and Mortality of Hemodialysis Patients.” Kidney International,
vol. 52, 1997, pp. 1096–1101., doi: 10.1038/ki.1997.434.

Roller 16
8. Moore II, J.P.; Dachavaram, S.S.; Bommagani, S.; Penthala, N.R.; Venkatraman, P.; Foster,
E.J.; Crooks, P.A.; A. Hestekin, J. “Oxone®-Mediated TEMPO-Oxidized Cellulose
Nanomaterials form I and form II.” Molecules 2020, 25, 1847.
9. Robling, K. 2019, “Characterization of Oxone Mediated TEMPO-Oxidized Nano Cellulose
Mixed-Matrix Membranes During Ultrafiltration and Hemodialysis”, Undergraduate
thesis, University of Arkansas, Fayetteville.
10. Dachavaram, S.S.; Moore, J.P.; Bommagani, S.; Penthala, N.R.; Calahan, J.L.; Delaney, S.P.;
Munson, E.J.; Batta-Mpouma, J.; Kim, J.; Hestekin, J.A. “A Facile Microwave Assisted
TEMPO/NaOCl/Oxone (KHSO5) Mediated Micron Cellulose Oxidation Procedure:
Preparation of Two Nano TEMPO-Cellulose Forms.” Starch-Stärke 2020, 72, 1900213.

